OTC Markets OTCPK - Delayed Quote • USD
Ampio Pharmaceuticals, Inc. (AMPE)
At close: 3:40 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Operating Expense
9,518.0000
9,518.0000
20,382.0000
20,571.0000
15,834.0000
--
Operating Income
-9,518.0000
-9,518.0000
-20,382.0000
-20,571.0000
-15,834.0000
--
Net Non Operating Interest Income Expense
348.0000
348.0000
220.0000
4.0000
12.0000
--
Other Income Expense
538.0000
538.0000
3,825.0000
3,492.0000
-72.0000
--
Pretax Income
-8,632.0000
-8,632.0000
-16,337.0000
-17,075.0000
-15,894.0000
--
Net Income Common Stockholders
-8,632.0000
-8,632.0000
-16,337.0000
-17,075.0000
-15,894.0000
--
Average Dilution Earnings
--
--
-5,761.0000
--
--
--
Diluted NI Available to Com Stockholders
-8,632.0000
-8,632.0000
-22,098.0000
-17,075.0000
-15,894.0000
--
Basic EPS
-10.66
--
-21.68
-27.00
-27.00
-30.00
Diluted EPS
-10.66
--
-29.32
-30.00
-27.00
-42.00
Basic Average Shares
810.1130
--
753.6150
664.3300
576.1550
435.3380
Diluted Average Shares
810.1130
--
753.6150
683.2100
576.1550
437.1170
Total Expenses
9,518.0000
9,518.0000
20,382.0000
20,571.0000
15,834.0000
--
Net Income from Continuing & Discontinued Operation
-8,632.0000
-8,632.0000
-16,337.0000
-17,075.0000
-15,894.0000
--
Normalized Income
-8,576.0000
-8,576.0000
-20,162.0000
-20,567.0000
-15,822.0000
--
Interest Income
348.0000
348.0000
220.0000
4.0000
12.0000
--
Net Interest Income
348.0000
348.0000
220.0000
4.0000
12.0000
--
EBIT
-9,518.0000
-9,518.0000
-20,382.0000
-20,571.0000
-15,834.0000
--
EBITDA
-9,396.0000
-9,396.0000
-19,334.0000
-19,477.0000
-14,657.0000
--
Reconciled Depreciation
122.0000
122.0000
1,048.0000
1,094.0000
1,177.0000
--
Net Income from Continuing Operation Net Minority Interest
-8,632.0000
-8,632.0000
-16,337.0000
-17,075.0000
-15,894.0000
--
Total Unusual Items Excluding Goodwill
-56.0000
-56.0000
3,825.0000
3,492.0000
-72.0000
--
Total Unusual Items
-56.0000
-56.0000
3,825.0000
3,492.0000
-72.0000
--
Normalized EBITDA
-9,340.0000
-9,340.0000
-23,159.0000
-22,969.0000
-14,585.0000
--
12/31/2019 - 7/31/2008
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
GRI GRI Bio, Inc.
0.2618
-1.21%
ARTL Artelo Biosciences, Inc.
1.3750
+1.85%
ARDS Aridis Pharmaceuticals, Inc.
0.0664
-5.14%
CMND Clearmind Medicine Inc.
1.0200
0.00%
AZTR Azitra, Inc.
0.1500
-1.25%
QNRX Quoin Pharmaceuticals, Ltd.
0.7389
-2.13%
BLPH Bellerophon Therapeutics, Inc.
0.0650
+8.33%
HSTO Histogen Inc.
0.3000
0.00%
VINC Vincerx Pharma, Inc.
0.7367
+2.98%
SLGL Sol-Gel Technologies Ltd.
0.7500
-1.45%